Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2585 (LINC02585) is a long non-coding RNA, more specifically a long intergenic non-coding RNA, identified in the human genome. Like other lincRNAs, it is a non-protein-coding transcript longer than 200 nucleotides that does not overlap with protein-coding genomic regions[1][3][7]. LincRNAs as a class are known to regulate gene expression through diverse mechanisms, including chromatin remodeling, transcriptional regulation, and influencing RNA stability or translation, often in a tissue-specific manner[7]. LINC02585 is also known by the alias CELSR3-AS1[3]. There is currently no direct evidence that LINC02585 functions as a therapeutic target, interacts with drugs, or is used as a biomarker. While many lincRNAs play important roles in disease processes, such as cancer, specific functional or disease associations for LINC02585 have not yet been reported in the literature. The general study and annotation of lincRNAs such as LINC02585 are expanding knowledge of non-coding genomic regions in molecular biology and disease[7].
Not applicable; not an established drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2585 (LINC02585).